MapLight Therapeutics, Inc.
(MPLT)Financial Statements · SEC EDGAR XBRL
Net Income
-$161.2M
-107.7%
EPS
$-18.56
+82.4%
Op. Income
-$169.1M
-103.8%
FCF
-$138.6M
-74.2%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)